Epidemiology of rare anaemias in europe

Advances in Experimental Medicine and Biology

Volumn 686, Issue , 2010, Pages 375-396

  Vives Corrons, Joan Lluis ^a   Gulbis, Beatrice ^b   Eleftheriou, Androulla ^b   Angastiniotis, Michael ^b   Ball, Sarah ^b   Surrallés, Jordi ^b   Castella, María ^b   Heimpel, Hermann ^b   Hill, Anita ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NONE

Author keywords

Anaemia; Congenital red cell aplasia; Epidemiology; Erythropoieis; Genetic screening; Migrations prevention; Paroxysmal nocturnal haemoglobinuria; Red blood cells; Sickle cell anaemia; Thalassaemia

Indexed keywords

ANEMIA; ARTICLE; BLACKFAN DIAMOND ANEMIA; CONGENITAL DYSERYTHROPOIETIC ANEMIA; DISEASE REGISTRY; EUROPE; FANCONI ANEMIA; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HEMOGLOBIN SC DISEASE; HEREDITARY HEMOLYTIC ANEMIA; HEREDITARY SPHEROCYTOSIS; HUMAN; IMMIGRATION; INCIDENCE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PREVALENCE; PRIORITY JOURNAL; RARE ANEMIA; RISK FACTOR; THALASSEMIA; FEMALE; GENETICS; HEMOGLOBINOPATHY; MALE; NEWBORN; RARE DISEASE; REGISTER; REVIEW;

ANEMIA; ANEMIA, DIAMOND-BLACKFAN; ANEMIA, DYSERYTHROPOIETIC, CONGENITAL; EUROPE; FANCONI ANEMIA; FEMALE; HEMOGLOBINOPATHIES; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; INFANT, NEWBORN; MALE; PREVALENCE; RARE DISEASES; REGISTRIES;

EID: 79952053030     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-90-481-9485-8_22     Document Type: Article

References (103)

1. Ahmed MR, Zaki M, Sabry MA, Higgs D, Vyas P, Wood WG et al (2006) Evidence of genetic heterogeneity in congenital dyserythropoietic anaemia type I. Br J Haematol 133(4):444-445
2. Alter BP (2003) Cancer in Fanconi anemia, 1927-2001. Cancer 97(2):425-440
3. Alter BP (2003) Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Look AT, Ginsburg D (eds) Nathan and Oski's Hematology of Infancy and Childhood. WB Saunders, Philadelphia, PA, pp 280-365
4. Anselstetter V, Horstmann K, Heimpel H (1977) Congenital dyserythropoetic anaemia, types I and II :Aberrant pattern of erythrocyte membrane proteins in CDA II, as revealed by twodimensional polyacrylamide gel electrophoresis. Br J Haematol 35:209-215 (Pubitemid 8048245)
5. Aronson JK (2006) Rare diseases, orphan drugs, and orphan diseases. Br Med J 333, 127
6. Auerbach, AD (1998) A test for Fanconi's anemia. Blood 72(1):366-367
7. Ball SE, McGuckin CP, Jenkins G, Gordon-Smith EC (1996) Diamond-Blackfan anaemia in the UK: Analysis of 80 cases from a 20-year birth cohort. Br J Haematol 94:645-653 (Pubitemid 26308896)
8. Bardakdjian-Michau J, Bahuau M, Hurtrel D, Godart C, Riou J, Mathis M, Goossens M (2009) Neonatal screening for sickle cell disease in France. J Clin Pathol 62:31-33
9. Bento C, Relvas L, Vazão H, Campos J, Rebelo U, Ribeiro ML (2006) The use of capillary blood samplesin a large scale screening approach for the detection of b-Thalassemia and hemoglobin variants. Haematologica 91:1565 (Pubitemid 44736127)
10. Bergström I, Jacobsson L (1962) Hereditary benign erythroreticulosis. Blood 19:296-303
11. Bianchi P, Fermo E, Vercellati C, Boschetti C, Barcellini W, Iurlo A et al (2009) Congenital dyserythropoietic anemia type II (CDAII) s caused by mutations in the SEC23B gene. Hum Mutat 30(9):1292-11298
12. Bittles AH (2001) Consanguinity and its relevance to clinical genetics. Clin Genet 60:89-98 (Pubitemid 32791662)
13. Bogliolo M, Lyakhovich A, Callen E, CastellaM, Cappelli E, Ramirez MJ, Creus A, Marcos R, Kalb R, Neveling K, Schindler D, Surralles J (2007) Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. Embo J 26(5):1340-1351 (Pubitemid 46398698)
14. Bresters D, Bruin MCA, Van Dijken PJ (1991) Congenitale hypoplastische anemie in Nederland (1963-1989). Tijdschrift Kindergeneeskunde 59:203-210
15. Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD (1994) Hematologic abnormalities in Fanconi anemia: An International Fanconi Anemia Registry study. Blood 84(5):1650-1655 (Pubitemid 24273037)
16. Callen E, Casado JA, Tischkowitz MD, Bueren JA, Creus A, Marcos R, Dasi A, Estella JM, Munoz A, Ortega JJ, de Winter J, Joenje H, Schindler D, Hanenberg H, Hodgson SV, Mathew CG, Surralles J (2005) A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain. Blood 105(5):1946-1949 (Pubitemid 40731776)
17. Cela de Julián E, Dulín Iñiguez E, Guerrero Soler M, Arranz Leirado M, Galarón García P, Beléndez Bieler C, Bellón Cano JM, García Arias M, Cantalejo López A (2007) Evaluation of systematic neonatal screening for sickle cell diseases in Madrid three years after its introduction]. An Pediatr (Barc) 66:382-386 (Pubitemid 46806741)
18. Cmejla R, Cmejlova J, Handrkova H, Petrak J, Pospisilova D (2007) Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia. Hum Mutat 28:1178-1182 (Pubitemid 350250381)
19. Crookston JH, Godwin TF, Wightmann KJR, Dacie JV, Lewis SM, Patterson M (1966) Congenital dyserythropoietic anemia. Abstr XIth Congress Internat Soc Hematol, Sydney
20. Crosby WH (1951) Paroxysmal nocturnal hemoglobinuria; a classic description by PaulStrublin in 1882, and a bibliography of the disease. Blood 6(3):270-284
21. De Kerviler E, Guermazi A, Zagdanski AM, Gluckman E, Frija J (2000) The clinical and radiological features of Fanconi's anaemia. Clin Radiol 55(5):340-345 (Pubitemid 32054491)
22. Dgany O, Avidan N, Delaunay J, Krasnov T, Shalmon L, Shalev H et al (2002) Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Hum Genet 71(6):1467-1474 (Pubitemid 36015901)
23. Dickerhoff R, Genzel-Boroviczeny O, Kohne E (2009) Haemoglobinopathies and newborn haemoglobinopathy screening in Germany. J Clin Pathol 62:34
24. Draptchinskaia N, Gustavsson P, Andersson B, Pettersson M, Willig TN, Dianzani I, Ball S, Tchernia G, Klar J, Matsson H, Tentler D, Mohandas N, Carlsson B, Dahl N (1999) The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet. 21:169-175 (Pubitemid 29070361)
25. European Commission. DG Health and Consumer Protection (2009) European Network For Rare And Congenital Anaemias. http://ec.europa.eu/health/ph- projects/2004/action1/action1-2004-23-en.htm#1
26. Faivre L, Portnoi MF, Pals G, Stoppa-Lyonnet D, Le Merrer M, Thauvin-Robinet C, Huet F, Mathew CG, Joenje H, Verloes A, Baumann C (2005) Should chromosome breakage studies be performed in patients with VACTERL association? Am J Med Genet 137(1):55-58 (Pubitemid 41105536)
27. Fanconi G (1927) Familiäre infantile perniziosaartige Anämie (perniziöses Blutbild und Konstitution). In: Jahrbuch für Kinderheilkunde und physische 257-280
28. Farrar JE, Nater M, Caywood E, McDevitt MA, Kowalski J, Takemoto CM, Talbot CC Jr, Meltzer P, Esposito D, Beggs AH, Schneider HE, Grabowska A, Ball SE, Niewiadomska E, Sieff CA, Vlachos A, Atsidaftos E, Ellis SR, Lipton JM, Gazda HT, Arceci RJ (2008) Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia. Blood 112:1582-1592
29. Gazda HT, Sheen MR, Vlachos A, Choesmel V, O'Donohue MF, Schneider H, Darras N, Hasman C, Sieff CA, Newburger PE, Ball SE, Niewiadomska E, Matysiak M, Zaucha JM, Glader B, Niemeyer C, Meerpohl JJ, Atsidaftos E, Lipton JM, Gleizes PE, Beggs AH (2008) Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet 83:769-780
30. Gazda HT, Grabowska A, Merida-Long LB, Latawiec E, Schneider C, Lipton, JM, Vlachos A, Atsidaftos E, Ball SE, Orfali KA, Niewiadomska E, Da Costa L, Tchernia G, Niemeyer C, Meerpohl JJ, Stahl J, Schratt G, Glader B, Backer K, Wong C, Nathan DG, Beggs AH, Sieff CA (2006) Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am J Hum Genet 79:1110-1118 (Pubitemid 44868071)
31. Giordano PC (2009) Starting neonatal screening for haemoglobinopathies in the Netherlands. J Clin Pathol 62:18-21
32. Giri N, Batista DL, Alter BP, Stratakis CA (2007) Endocrine abnormalities inpatients with Fanconi anemia. J Clin Endocrinol Metab 92(7):2624-2631 (Pubitemid 47037367)
33. Goede JS, Benz R, Fehr J, Schwarz K, Heimpel H (2006) Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy. Ann Hematol 85:591-595 (Pubitemid 44283079)
34. Gulbis B, Cotton F, Ferster A, Ketelslegers O, Dresse M-F, Rongé-Collard E, Minon JM, Lé PQ, Vertongen F (2009) Neonatal haemoglobinopathy screening in Belgium. J Clin Pathol 62:49-52
35. Haematological Malignancy Diagnostic Service (HMDS) (2009) Paroxysmal Nocturnal Haemoglobinuria (PNH). http://www.hmds.org.uk/
36. Heimpel H, Schwarz K, EbnötherM, Goede JS, Heydrich D, Kamp T et al (2006) Congenital dyserythropoietic anemia type I (CDA I): Molecular genetics, clinical appearance and prognosis based on long-term observation. Blood 107(1):334-340 (Pubitemid 43053560)
37. Heimpel H, Wendt F (1967) Eine neue Variante der kongenitalen dyserythropoietischen Anämie. Schweiz Med Wochenschr 97:1470-1471
38. Heimpel H, Wendt F (1968) Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts. Helv Med Acta 34:103-115
39. Hickman M, Modell B, Greengross P, Chapman C, Layton M, Gill M, Davis S (1999) Mapping the prevalence of beta thalassaemia and sickle cell haemoglobin in England: Recommended rates for local service planning. Br J Haematol 104:860-867 (Pubitemid 29143509)
40. Hill A, Platts PJ, Smith A, Richards SJ, Cullen MJ, Hill QA, et al (2006) The Incidence and Prevalence of Paroxysmal Nocturnal Hemoglobinuria (PNH) and Survival of Patients in Yorkshire. Blood 108(11):294a
41. Hillmen P, Hall C, Marsh JC, Elebute M, Bombara MP, Petro BE, et al (2004) Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 350(6):552-559 (Pubitemid 38160785)
42. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV (1995) Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 333(19):1253-1258
43. Hirsch B, Shimamura A, Moreau L, Baldinger S, Hag-alshiekh M, Bostrom B, Sencer S, D'Andrea AD (2004) Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. Blood 103(7):2554-2559 (Pubitemid 38393006)
44. Iolascon A, D'Agostaro G, Perrotta S, Izzo P, Tavano R, Miraglia del Giudice B (1996) Congenital dyserythropoietic anemia type II: Molecular basis and clinical aspects. Haematologica 81(6):543-559
45. Issaragrisil S, Sriratanasatavorn C, Piankijagum A, Vannasaeng S, Porapakkham Y, Leaverton PE, et al (1991) Incidence of aplastic anemia in Bangkok. The Aplastic Anemia Study Group. Blood 77(10):2166-2168
46. Janov AJ, Leong T, Nathan DG, Guinan EC (1996) Diamond-Blackfan anemia. Natural history and sequelae of treatment. Medicine (Baltimore) 75:77-8
47. Joenje H, Patel KJ (2001) The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet 2(6):446-457 (Pubitemid 33673411)
48. Kalb R, Neveling K, Hoehn H, Schneider H, Linka Y, Batish SD, Hunt C, Berwick M, Callen E, Surralles J, Casado JA, Bueren J, Dasi A, Soulier J, Gluckman E, Zwaan CM, van Spaendonk R, Pals G, de Winter JP, Joenje H, Grompe M, Auerbach AD, Hanenberg H, Schindler D (2007) Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype. Am J Hum Genet 80(5):895-910 (Pubitemid 46668458)
49. Kennedy RD, D'Andrea AD (2005) The Fanconi Anemia/BRCA pathway: New faces in the crowd. Genes Dev 19(24):2925-2940 (Pubitemid 41798109)
50. Kruatrachue M, Wasi P, Na-Nakorn S (1978) Paroxysmal nocturnal haemoglobinuria in Thailand with special reference to as association with aplastic anaemia. Br J Haematol 39(2):267-276 (Pubitemid 8372842)
51. Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF, Hanenberg H, Auerbach AD (2003) A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101(4):1249-1256 (Pubitemid 36182492)
52. Lewis SM, Verwilghen RL (1977) Dyserythropoiesis. Academic Press, London
53. Lipton JM, Federman N, Khabbaze Y, Schwartz CL, Hilliard LM, Clark JI, Vlachos A; Diamond-Black Anemia Registry (2001) Osteogenic sarcoma associated with Diamond- Blackfan anemia: A report from the Diamond-Blackfan Anemia Registry. J Pediatr Hematol Oncol 23:39-44 (Pubitemid 32140371)
54. Lyakhovich A, Surralles J (2007) New roads to FA/BRCA pathway: H2AX. Cell Cycle 6(9):1019-1023 (Pubitemid 46708572)
55. Mañú PereiraM, Vives Corrons J-L (2009) Neonatal haemoglobinopathy screening in Spain. J Clin Pathol 62:22-25
56. Modell B, Darlinson M, Birgens H et al (2007) Epidemiology of haemoglobin disorders in Europe: An overview. Scand J Clin Lab Invest 67:39-70
57. Modell B, Darlison M, Birgens H, Cario H, Faustino P, Giordano P et al (2007) Epidemiology of haemoglobin disorders in Europe: An overview. Scand J Clin Lab Invest 67:39-70
58. Modell B, Darlison M (2008) Global epidemiology of haemoglobin disorders and derived service indicators. Bull WHO 86(6):480-487 (Pubitemid 351821761)
59. Orfali RF, Wynn RF, Stevens RF, Chopra R, Ball SE (1999) Failure of red cell production following allogenic BMT for Diamond Blackfan anaemia (DBA) illustrates functional significance of high erythrocyte adenosine deaminase (eADA) activity in the donor. Blood 94:414a
60. Orfali KA, Ohene-Abuakwa Y, Ball SE (2004) Diamond Blackfan anaemia in the UK: Clinical and genetic heterogeneity. Br J Haematol 125:243-252 (Pubitemid 38534978)
61. Orphanet (2004) Paroxysmal Nocturnal Hemoglobinuria. http://www.orpha. net/consor/cgibin/OC-Exp.php?lng=EN&Expert=447
62. Paquette RL, Yoshimura R, Veiseh C, Kunkel L, Gajewski J, Rosen PJ (1997) Clinical characteristics predict response to antithymocyte globulin in paroxysmal nocturnal haemoglobinuria. Br J Haematol 96(1):92-97
63. Porter R, Fitzsimons DW (1976) Congenital disorders of erythropoiesis. Elsevier, Amsterdam
64. Pramoonjago P, Pakdeesuwan K, Siripanyaphinyo U, Chinprasertsuk S, Kinoshita T, Wanachiwanawin W (1999) Genotypic, immunophenotypic and clinical features of Thai patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 105(2):497-504 (Pubitemid 29232177)
65. Ramenghi U, Garelli E, Valtolina S, Campagnoli MF, Timeus F, Crescenzio N, Mair M, Varotto S, D'Avanzo M, Nobili B, Massolo F, Mori PG, Locatelli F, Gustavsson P, Dahl N, Dianzani I (1999) Diamond-Blackfan anaemia in the Italian population. Br J Haematol 104:841-848 (Pubitemid 29143506)
66. Rare Thrombotic Diseases Consortium (2000) Paroxysmal nocturnal hemoglobinuria
67. Raya A, Rodriguez-Piza I, Guenechea G, Vassena R, Navarro S, Barrero MJ, Consiglio A, Castella M, Rio P, Sleep E, Gonzalez F, Tiscornia G, Garreta E, Aasen T, Veiga A, Verma IM, Surralles J, Bueren, Belmonte JC (2009) Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460(7251):53-59
68. Rio P, Meza NW, Gonzalez-Murillo A, Navarro S, Alvarez L, Surralles J, Castella M, Guenechea G, Segovia JC, Hanenberg H, Bueren JA (2008) In vivo proliferation advantage of genetically corrected hematopoietic stem cells in a mouse model of Fanconi anemia FA-D1. Blood 112(13):4853-4861
69. Rosenberg, PS, Socie G, BP Alter, Gluckman E (2005) Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 105(1) 67-73 (Pubitemid 40053065)
70. Rosse WF (1996) Epidemiology of PNH. Lancet 348(9027):560 (Pubitemid 26283882)
71. Rosti V (2005) The molecular basis of paroxysmal nocturnal hemoglobinuria. Haematologica 85(1):82-87
72. Rother RP, Bell L, Hillmen P, Gladwin MT (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. JAMA 293(13):1653-1662 (Pubitemid 40471796)
73. Ru YX, Zhu XF, Yan WW, Gao JT, Schwarz K, Heimpel H (2008) Congenital dyserythropoietic anemia in a Chinese family with a mutation of the CDAN1-gene. Ann Hematol 87(9):751-754
74. Sagaseta de Ilurdoz M, Molina J, Lezaun I, Valiente A, Duran G (2003) Updating Fanconi's anaemia. An Sist Sanit Navar 26(1):63-78 (Pubitemid 36578229)
75. Sandstroem H, Wahlin A (2000) Congenital dyserythropoietic anemia type III. Haematologica 85(7):753-757 (Pubitemid 30617110)
76. Sansone G (1999) Le Anemie diserythropoetiche congenite. Pacini, Pisa
77. Scartezzini P, Forni GL, Baldi M, et al (1982) Decreased glycosylation of band 3 and band 4.5 glycoproteins of erythrocyte membrane in congenital dyserythropoietic anaemia type II. Br J Haematol 51:569-576 (Pubitemid 12049990)
78. Schroeder TM (1966) Cytogenetic and cytologic findings in enzymopenicpanmyelopathies and pancytopenias. Familial myelopathy of Fanconi, glutathione-reductase deficiency anemia and megaloblastic B12 deficiency anemia. Humangenetik 2(3):287316
79. Schuler D, Kiss A, Fabian F (1969) Chromosome studies in Fanconi's anemia. Orv Hetil 110(13):713-720
80. Schwarz K, Iolascon A, Verissimo F, Trede NS, Horsley W, Chen W et al (2009) Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet 41(8):936-940
81. SessionEB117/34 (2006) http://www.who.int/genomics/publications/WHO- MODreportfinal. Pdf
82. Socie G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C, et al (1996) Paroxysmal nocturnal haemoglobinuria: Long-term follow-up and prognostic factors. French Society of Haematology. Lancet 348(9027):573-577 (Pubitemid 26283888)
83. Strathdee CA, Gavish H, Shannon WR, Buchwald M (1992) Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 356(6372):763-767
84. Streetly A, Latinovic R, Hall K, Henthorn J (2009) Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: Screening results for 2005-7. J Clin Pathol 62:26-30
85. Tabbara IA (1992) Hemolytic anemias. Diagnosis and management. Med Clin North Am 76(3):649-668
86. Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, et al (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73(4):703-711 (Pubitemid 23159009)
87. Tamary H, Dgany O, Proust A, Krasnov T, Avidan N, Eidelitz-Markus T et al (2005) Clinical and molecular variability in congenital dyserythropoietic anaemia type I. Br J Haematol 130(4):628-634 (Pubitemid 43899768)
88. Tamary H, Shalmon L, Shalev H, Shaft D, Zoldan M, Resnitzky P et al (1996) Lokalisation of the gene for congenital dyserythropoietic anemia type I to chromosome 15q15.1.3. Blood 88(Suppl. 1):144
89. Tipping, AJ, Pearson T, Morgan NV, Gibson RA, Kuyt LP, Havenga C, Gluckman E, Joenje H, de Ravel T, Jansen S, Mathew CG (2001) Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa. Proc Natl Acad Sci U S A 98(10):5734-5739 (Pubitemid 32435711)
90. Tudela M, Jarque I, Perez-Sirvent ML, Palau J, Sanz MA (1993) Clinical profile and course of paroxysmal nocturnal hemoglobinuria. Sangre (Barc ) 38(4):301-307
91. van Zeeburg HJ, Snijders PJ, Wu T, Gluckman E, Soulier J, Surralles J, Castella M, van der Wal JE, Wennerberg J, Califano J, Velleuer E, Dietrich R, Ebell W, Bloemena E, Joenje H, Leemans CR, Brakenhoff RH (2008) Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst 100(22):1649-1653
92. Vives Corrons JL (2009) Red blood cell enzymopathies. In: Beaumont C, Beris P, Beuzard Y, Brugnara C (eds) The handbook 2009: Disorders of erythropoiesis, erythrocytes and iron metabolism. ISBN 978-88-89620-13-7
93. Vlachos A, Ball S, Dahl N, Alter BP, Sheth S, Ramenghi U, Meerpohl J, Karlsson S, Liu JM, Leblanc T, Paley C, Kang EM, Leder EJ, Atsidaftos E, Shimamura A, Bessler M, Glader B, Lipton JM; on behalf of the participants of the Sixth Annual Daniella Maria Arturi International Consensus Conference (2008) Diagnosing and treating Diamond Blackfan anaemia: Results of an international clinical consensus conference. Br J Haematol. 142:859-876
94. Vlachos A, Klein GW, Lipton JMJ (2001) The Diamond Blackfan Anemia Registry: Tool for investigating the epidemiology and biology of Diamond-Blackfan anemia. Pediatr Hematol Oncol 23:377-382 (Pubitemid 32845667)
95. Wajnrajch MP, Gertner JM, Huma Z, Popovic J, Lin K, Verlander PC, Batish SD, Giampietro PF, Davis JG, New MI, Auerbach AD (2001) Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics 107(4):744-754 (Pubitemid 32268460)
96. Wang X, Kennedy RD, Ray K, Stuckert P, Ellenberger T, D'Andrea AD (2007) Chk1 mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway. Mol Cell Biol 27(8):3098-3108 (Pubitemid 46581321)
97. Wendt F, Heimpel H (1967) Kongenitale dyserythropoetische Anämie bei einem zweieiigen Zwillingspaar. Med Klinik 62:172-177
98. Whitney MA, Saito H, Jakobs PM, Gibson RA, Moses RE, Grompe M (1993) A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews. Nat Genet 4(2): 202-205 (Pubitemid 23179108)
99. Wickramasinghe SN, Wood WG (2005) Advances in the understanding of the congenital dyserythropoietic anaemias. Br J Haematol 131(4):431-446 (Pubitemid 43899640)
100. Wiedmer T, Hall SE, Ortel TL, Kane WH, Rosse WF, Sims PJ (1993) Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 82(4):1192-1196 (Pubitemid 23253993)
101. Willig TN, Pérignon JL, Gustavsson P, Gane P, Draptchinskaya N, Testard H, Girot R, Debré M, Stéphan JL, Chenel C, Cartron JP, Dahl N, Tchernia G (1998) High adenosine deaminase level among healthy probands of Diamond Blackfan anemia (DBA) cosegregates with the DBA gene region on chromosome 19q13. The DBA Working Group of Société d'Immunologie Pédiatrique (SHIP). Blood 92:4422-4427 (Pubitemid 28544360)
102. Willig TN, Draptchinskaia N, Dianzani I, Ball S, Niemeyer C, Ramenghi U, Orfali K, Gustavsson P, Garelli E, Brusco A, Tiemann C, Perignon JL, Bouchier C, Cicchiello L, Dahl N, Mohandas N, Tchernia G (1999a) Mutations in ribosomal protein S19 gene and diamond blackfan anemia: Wide variations in phenotypic expression. Blood 94:4294-4306
103. Willig TN, Niemeyer CM, Leblanc T, Tiemann C, Robert A, Budde J, Lambiliotte A, Kohne E, Souillet G, Eber S, Stephan JL, Girot R, Bordigoni P, Cornu G, Blanche S, Guillard JM, Mohandas N, Tchernia G (1999b) Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Societe d'Hematologie et d'Immunologie Pediatrique (SHIP), Gesellshaft fur Padiatrische Onkologie und Hamatologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI). Pediatr Res 46:553-561